Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients

The Therapeutic Potential of Cannabis and Cannabinoids

(2018) Franjo Grotenhermen et al.   Deutsches Arzteblatt International

Meta-analysis of placebo responses in central neuropathic pain

(2016) Jacquelyn J. Cragg et al.   PAIN

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

(2015) Susan Ball et al.   HEALTH TECHNOLOGY ASSESSMENT

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients

(2015) Damiano Paolicelli et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

(2015) Nanna B Finnerup et al.   LANCET NEUROLOGY

Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice

(2014) Peter Flachenecker et al.   EUROPEAN NEUROLOGY

A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain

(2014) B. Hoggart et al.   JOURNAL OF NEUROLOGY

The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals with Chronic Non-cancer Pain

(2013) Mark J. Edlund et al.   CLINICAL JOURNAL OF PAIN

The placebo response in medicine: minimize, maximize or personalize?

(2013) Paul Enck et al.   NATURE REVIEWS DRUG DISCOVERY

A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury

(2013) D. D. Cardenas et al.   NEUROLOGY

Neuropathic pain in the community: More under-treated than refractory?

(2013) Nicola Torrance et al.   PAIN

A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis

(2013) Timothy L. Vollmer et al.   Pain Practice

Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis

(2012) Michael G. Serpell et al.   JOURNAL OF NEUROLOGY

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

(2012) R. M. Langford et al.   JOURNAL OF NEUROLOGY

The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials

(2011) Gaetano Zaccara et al.   EPILEPSIA

Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors

(2011) Fabrizio Benedetti et al.   NATURE MEDICINE

Safety and efficacy of pregabalin in patients with central post-stroke pain

(2011) Jong S. Kim et al.   PAIN

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

(2010) Robert H. Dworkin et al.   MAYO CLINIC PROCEEDINGS

Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: A randomized, double-blind, placebo-controlled trial

(2010) J. H. Vranken et al.   PAIN

Tramadol in Neuropathic Pain After Spinal Cord Injury

(2009) Cecilia Norrbrink et al.   CLINICAL JOURNAL OF PAIN

Pain associated with multiple sclerosis: Systematic review and proposed classification

(2007) Alec B. O’Connor et al.   PAIN

Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen

(2007) J. H. Vranken et al.   PAIN